|
KLC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.149360E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.159500E-02 |
| Normal-vs-Stage2 |
9.225200E-01 |
| Normal-vs-Stage3 |
7.033600E-01 |
| Normal-vs-Stage4 |
6.794000E-01 |
| Stage1-vs-Stage2 |
3.706400E-02 |
| Stage1-vs-Stage3 |
2.882400E-02 |
| Stage1-vs-Stage4 |
6.953800E-02 |
| Stage2-vs-Stage3 |
6.685400E-01 |
| Stage2-vs-Stage4 |
6.628400E-01 |
| Stage3-vs-Stage4 |
9.518800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.118800E-01 |
| Normal-vs-AfricanAmerican |
6.385500E-04 |
| Normal-vs-Asian |
5.141900E-02 |
| Caucasian-vs-AfricanAmerican |
1.295300E-03 |
| Caucasian-vs-Asian |
1.326040E-01 |
| AfricanAmerican-vs-Asian |
8.792400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.255600E-01 |
| Normal-vs-Female |
7.858000E-02 |
| Male-vs-Female |
3.154800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.679900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.713800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.239400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.075000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.065600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.504600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.438300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.155430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.666400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.154400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.12410000000652E-05 |
| Normal-vs-Grade 2 |
7.121400E-03 |
| Normal-vs-Grade 3 |
9.376400E-01 |
| Normal-vs-Grade 4 |
7.750400E-01 |
| Grade 1-vs-Grade 2 |
6.430400E-04 |
| Grade 1-vs-Grade 3 |
2.48160000004827E-06 |
| Grade 1-vs-Grade 4 |
2.10499999999669E-05 |
| Grade 2-vs-Grade 3 |
3.389400E-04 |
| Grade 2-vs-Grade 4 |
5.004300E-02 |
| Grade 3-vs-Grade 4 |
6.981000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.800800E-01 |
| Normal-vs-ccB subtype |
3.034800E-01 |
| ccA subtype-vs-ccB subtype |
9.072000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.931200E-01 |
| Normal-vs-N1 |
4.069000E-01 |
| N0-vs-N1 |
2.779000E-01 |
|
|
